Related Experiment Video
Updated: Jun 27, 2026

Yeast As a Chassis for Developing Functional Assays to Study Human P53
Published on: August 4, 2019
Rescuing the function of mutant p53
1Department of Biochemistry, University of Washington, Seattle, USA.
Abstract:
One protein--p53--plays nemesis to most cancers by condemning damaged cells to death or quarantining them for repair. But the activity of p53 relies on its intact native conformation, which can be lost following mutation of a single nucleotide. With thousands of such mutations identified in patients, how can a future cancer drug buttress this fragile protein structure and restore the cell's natural defence?
Insights
The tumor suppressor protein p53 is crucial for cancer prevention, but mutations can inactivate it. Future cancer drugs may aim to restore p53
Area of Science:
- Oncology
- Molecular Biology
- Protein Biochemistry
Background:
- The tumor suppressor protein p53 is a critical cellular component that prevents cancer development.
- p53 functions by inducing cell death or cell cycle arrest in cells with damaged DNA.
- The therapeutic efficacy of p53 is contingent upon its native, intact three-dimensional structure.
Purpose of the Study:
- To explore therapeutic strategies for restoring the function of mutated p53 in cancer.
- To investigate methods for stabilizing the native conformation of the p53 protein.
- To identify potential drug targets that can reactivate p53's tumor-suppressive activities.
Main Methods:
- Analysis of p53 mutations identified in cancer patients.
- Computational modeling to understand p53 protein structure and stability.
- In vitro and in vivo assays to evaluate the effects of potential therapeutic interventions.
Main Results:
- Identified numerous p53 mutations that compromise its native conformation and function.
- Demonstrated that single nucleotide changes can lead to significant loss of p53 activity.
- Highlighted the challenge of restoring p53 function due to its structural fragility.
Conclusions:
- p53's critical role in cancer prevention is often subverted by mutations affecting its structure.
- Developing drugs that can stabilize or restore the native p53 conformation is a promising therapeutic avenue.
- Further research is needed to identify and develop effective p53-restoring cancer therapies.
Related Concept Videos
Negative Regulator Molecules
DNA Damage can Stall the Cell Cycle
Abnormal Proliferation
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
DNA Damage Can Stall the Cell Cycle
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...

